These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38671866)

  • 1. 7-
    Romanucci V; Pagano R; Kandhari K; Zarrelli A; Petrone M; Agarwal C; Agarwal R; Di Fabio G
    Antioxidants (Basel); 2024 Mar; 13(4):. PubMed ID: 38671866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-cancer efficacy of silybin derivatives -- a structure-activity relationship.
    Agarwal C; Wadhwa R; Deep G; Biedermann D; Gažák R; Křen V; Agarwal R
    PLoS One; 2013; 8(3):e60074. PubMed ID: 23555889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphodiester Silybin Dimers Powerful Radical Scavengers: A Antiproliferative Activity on Different Cancer Cell Lines.
    Romanucci V; Pagano R; Lembo A; Capasso D; Di Gaetano S; Zarrelli A; Di Fabio G
    Molecules; 2022 Mar; 27(5):. PubMed ID: 35268803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silibinin derivatives as anti-prostate cancer agents: Synthesis and cell-based evaluations.
    Vue B; Zhang S; Zhang X; Parisis K; Zhang Q; Zheng S; Wang G; Chen QH
    Eur J Med Chem; 2016 Feb; 109():36-46. PubMed ID: 26748997
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Vue B; Zhang S; Vignau A; Chen G; Zhang X; Diaz W; Zhang Q; Zheng S; Wang G; Chen QH
    Molecules; 2018 Nov; 23(12):. PubMed ID: 30501133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation on the solid-phase synthesis of silybin prodrugs and their timed-release.
    Romanucci V; Giordano M; Pagano R; Zimbone S; Giuffrida ML; Milardi D; Zarrelli A; Di Fabio G
    Bioorg Med Chem; 2021 Nov; 50():116478. PubMed ID: 34695708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying the differential effects of silymarin constituents on cell growth and cell cycle regulatory molecules in human prostate cancer cells.
    Deep G; Oberlies NH; Kroll DJ; Agarwal R
    Int J Cancer; 2008 Jul; 123(1):41-50. PubMed ID: 18435416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antitumor activity of silybin nanosuspension in PC-3 cells.
    Zheng D; Wang Y; Zhang D; Liu Z; Duan C; Jia L; Wang F; Liu Y; Liu G; Hao L; Zhang Q
    Cancer Lett; 2011 Aug; 307(2):158-64. PubMed ID: 21507570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chirality Matters: Biological Activity of Optically Pure Silybin and Its Congeners.
    Křen V
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silibinin suppresses growth of human prostate carcinoma PC-3 orthotopic xenograft via activation of extracellular signal-regulated kinase 1/2 and inhibition of signal transducers and activators of transcription signaling.
    Singh RP; Raina K; Deep G; Chan D; Agarwal R
    Clin Cancer Res; 2009 Jan; 15(2):613-21. PubMed ID: 19147767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p21 and p27 induction by silibinin is essential for its cell cycle arrest effect in prostate carcinoma cells.
    Roy S; Kaur M; Agarwal C; Tecklenburg M; Sclafani RA; Agarwal R
    Mol Cancer Ther; 2007 Oct; 6(10):2696-707. PubMed ID: 17938263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic and Apoptotic Effects of Novel Pyrrolo[2,3-d]Pyrimidine Derivatives Containing Urea Moieties on Cancer Cell Lines.
    Kilic-Kurt Z; Bakar-Ates F; Karakas B; Kütük Ö
    Anticancer Agents Med Chem; 2018; 18(9):1303-1312. PubMed ID: 29866023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Core Structure-Activity Relationship Studies of 5,7,20-
    Wu S; Chen G; Chen EY; Farshidpour LS; Zhang Q; Wang G; Chen QH
    Pharmaceuticals (Basel); 2023 Apr; 16(4):. PubMed ID: 37111288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 7-O-aminoalkyl-2,3-dehydrosilibinins: Synthesis and in vitro Anti-cancer Efficacy.
    Ma DY; Zhang LC; Peng KJ; Zeng J; Liu LJ; Luo ZY; Liu SY
    Anticancer Agents Med Chem; 2018; 18(8):1156-1162. PubMed ID: 29607789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trehalose Conjugates of Silybin as Prodrugs for Targeting Toxic Aβ Aggregates.
    García-Viñuales S; Ahmed R; Sciacca MFM; Lanza V; Giuffrida ML; Zimbone S; Romanucci V; Zarrelli A; Bongiorno C; Spinella N; Galati C; Di Fabio G; Melacini G; Milardi D
    ACS Chem Neurosci; 2020 Sep; 11(17):2566-2576. PubMed ID: 32687307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silibinin inhibits prostate cancer invasion, motility and migration by suppressing vimentin and MMP-2 expression.
    Wu KJ; Zeng J; Zhu GD; Zhang LL; Zhang D; Li L; Fan JH; Wang XY; He DL
    Acta Pharmacol Sin; 2009 Aug; 30(8):1162-8. PubMed ID: 19578386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silibinin Schiff Base Derivatives Counteract CCl
    Xu R; Qiu S; Zhang J; Liu X; Zhang L; Xing H; You M; Wang M; Lu Y; Zhang P; Zhu J
    Drug Des Devel Ther; 2022; 16():1441-1456. PubMed ID: 35601675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silybin-Induced Apoptosis Occurs in Parallel to the Increase of Ceramides Synthesis and miRNAs Secretion in Human Hepatocarcinoma Cells.
    Zappavigna S; Vanacore D; Lama S; Potenza N; Russo A; Ferranti P; Dallio M; Federico A; Loguercio C; Sperlongano P; Caraglia M; Stiuso P
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31058823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct targeting of MEK1/2 and RSK2 by silybin induces cell-cycle arrest and inhibits melanoma cell growth.
    Lee MH; Huang Z; Kim DJ; Kim SH; Kim MO; Lee SY; Xie H; Park SJ; Kim JY; Kundu JK; Bode AM; Surh YJ; Dong Z
    Cancer Prev Res (Phila); 2013 May; 6(5):455-65. PubMed ID: 23447564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, Synthesis and Biological Evaluation of Glycosylated Derivatives of Silibinin as Potential Anti-Tumor Agents.
    Xi JJ; Cao Y; He RY; Zhang JK; Zhao YM; Tong Q; Bao JF; Dong YC; Zhuang RX; Huang JS; Chen Y; Liu SR
    Drug Des Devel Ther; 2023; 17():2063-2076. PubMed ID: 37457888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.